Immune thrombocytopenia and other extrahepatic manifestations of hepatitis C virus infection;Małopłytkowość immunologiczna i inne pozawa̧trobowe zaburzenia w przebiegu zakażenia wirusem zapalenia wa̧troby typu C

Gastroenterologia Polska

Volumn 13, Issue 3, 2006, Pages 208-210

  Berendt Obołończyk, Monika ^a   Kazimierska, Ewa ^a   Sworczak, Krzysztof ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Hepatitis C virus; Thrombocytopenia

Indexed keywords

CHRONIC HEPATITIS; CRYOGLOBULINEMIA; HASHIMOTO DISEASE; HEPATITIS C VIRUS; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; PORPHYRIA CUTANEA TARDA; REVIEW; THROMBOCYTOPENIA; VIRUS INFECTION;

EID: 33746374403     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Braczkowska B., Kowalska M.: Epidemiology of HCV infection in Poland and the world. Wiad. Lek., 2002, 55, supl. 1, 61-68.
2. Hwang S.J.: Hepatitis C virus infection: an overview. J. Microbiol. Immunol. Infect. 2001, 34, 227-234.
3. Cacoub P., Poynard T., Ghillani P., Charlotte F., Olivi M., Piette J.C., Opolon P.: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum., 1999, 42, 2204-2212.
4. Pawlotsky J.M., Roudot-Thoraval F., Simmonds P., Mellor J., Ben Yahia M.B., Andre C., Voisin M.C., Intrator L., Zafrani E.S., Duval J., Dhumeaux D.: Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann. Intern. Med., 1995, 122, 169-173.
5. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., Yamamoto A.M., Camproux A.C., Hausfater P., Musset L., Veyssier P., Raguin G., Piette J.C.: Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine (Baltimore), 2000, 79, 47-56.
6. Sene D., Ghillani-Dalbin P., Thibault V., Guis L., Musset L., Duhaut P., Poynard T., Piette J.C., Cacoub P.: Long term course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J. Rheumatol., 2004, 31, 2199-2206.
7. Agnello V., Chung R.T., Kaplan L.M.: A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med., 1992, 327, 1490-1495.
8. Misiani R., Bellavita P., Fenili D., Vicari O., Marchesi D., Sironi P.L., Zilio P., Vernocchi A., Massazza M., Vendramin G.: Interferon-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Engl. J. Med., 1994, 330, 751-756.
9. DeCastro M., Sanchez J., Herrera J.F., Chaves A., Duran R., Garcia-Buey L., Garcia-Monzon C., Sequi J., Moreno-Otero R.: Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology, 1993, 17, 551-557.
10. Fargion S., Piperno A., Cappellini M.D., Sampietro M., Fracanzani A.L., Romano R., Caldarelli R., Marcelli R., Vecchi L., Fiorelli G.: Hepatitis C virus and porphyria cutanea tarda: evidence of a strong assiciation. Hepatology, 1992, 16, 1322-1326.
11. Shan Y., Lambrecht R.W., Bonkovsky H.L.: Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin. Infect. Dis., 2005, 40, 834-841.
12. Haddad J., Deny P., Munz-Gotheil C., Ambrosini J.C., Trinchet J.C., Pateron D., Mal F., Callard P., Beaugrand M.: Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet, 1992, 339, 321-323.
13. Pawlotsky J.M., Ben Yahia M., Andre C., Voisin M.C., Intrator L., Roudot-Thoraval F., Deforges L., Duvoux C., Zafrani E.S., Duval J.: Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology, 1994, 19, 841-848.
14. Daghestani L., Pomeroy C.: Renal manifestations of hepatitis C infection. Am. J. Med., 1999, 106, 347-354.
15. Johnson R.J., Gretch D.R., Yamabe H., Hart J., Bacchi C.E., Hartwell P., Couser W.G., Corey L., Wener M.H., Alpers C.E.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med., 1993, 328, 505-506.
16. Wang C.S., Yao W.J., Wang S.T. Chang T.T., Chou P.: Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin. Infect. Dis., 2004, 39, 790-796.
17. Nagamine T., Ohtuka T., Takehara K., Arai T., Takagi H., Mori M.: Thrombocytopenia associated with hepatitis C viral infection. J. Hepatol., 1996, 25, 999.
18. Aster R.H.: Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J. Clin. Invest., 1966, 45, 645-657.
19. Guastafierro S., Sessa F., Tirelli A.: Biclonal gammapathy and platelet antibodies in a patient with chronic hepatitis C virus infection and mixed cryoglobulinemia. Ann. Hematol., 2000, 79, 463-464.
20. Silva M., Li X., Cheinquer H., Kolodny L., Raddic J., LaRhue S., Ahn Y.: HCV associated idiopathic thrombocytopenic purpura (ITP). Gastroenterology, 1992, 102, 889.
21. Pivetti S., Novarino A., Merico F., Bertero M.T., Brunetto M.R., Bonino F., Caligaris-Cappio F.: High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br. J. Haematol., 1996, 95, 204-211.
22. Pockros P.J., Duchini A., McMillan R., Nyberg L.M., McHutchison J., Viernes E.: Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol., 2002, 97, 2040-2045.
23. Bordin G., Ballare M., Zigrossi P., Bertoncelli M.C., Paccagnino L., Baroli A., Brambilla M., Monteverde A., Inglese E.: A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin. Exp. Rheumatol., 1995, 13, supl. 13, 39-43.
24. de Almeida A.J., Campos-de-Magalhaes M., de Melo Marcal O.P., Brandao-Mello C.E., Okawa M.Y., de Oliveira R.V., do Espirito-Santo M.P., Yoshida C.F., Lampe E.: Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study. Ann. Hematol., 2004, 83, 434-340.
25. Giannini E., Borro P., Botta F., Fumagalli A., Malfatti F., Podesta E., Romagnoli P., Testa E., Chiarbonello B., Polegato S., Mamone M., Testa R.: Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J. Hepatol., 2002, 37, 572-577.
26. Stockelberg D., Andersson P., Bjornsson E., Bjork S., Wadenvik H.: Plasma thrombopoietin levels in liver cirrhosis and kidney failure. J. Intern. Med., 1999. 246, 471-475.
27. Espanol I., Gallego A., Enriquez J., Rabella N., Lerma E., Hernandez A., Pujol-Moix N.: Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin. Hepatogastroenterology, 2000, 47, 1404-1406.
28. Zignego A.L., Ferri C., Giannini C., La Civita L., Careccia G., Longombardo G., Bellesi G., Caracciolo F., Thiers V., Gentilini P.: Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch. Viral., 1997, 142, 545-555.
29. Fernandez-Soto L., Gonzalez A., Escobar-Jimenez F., Vazquez R., Ocete E., Olea N., Salmeron J.: Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch. Intern. Med., 1998, 158, 1445-1448.
30. Fontaine H., Pol S.: Side Effects of Interferon-alpha in Treating Hepatitis C Virus Infection. Transplant. Proc., 2001, 33, 2327-2329.
31. Hsieh M.C., Yu M.L., Chuang W.L., Shin S.J., Dai C.Y., Chen S.C., Lin Z.Y., Hsieh M.Y., Liu J.F., Wang L.Y., Chang W.Y.: Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. Eur. J. Endocrinol., 2000, 142, 431-437.
32. Carella C., Mazziotti G., Morisco F., Manganella G., Rotondi M., Tuccillo C., Sorvillo F., Caporaso N., Amato G.: Long-Term Outcome of Interferon-alpha-Induced Thyroid Autoimmunity and Prognostic Influence of Thyroid Autoantibody Pattern at the End of Treatment. J. Clin. Endocrin. Metab., 2001, 86, 1925-1929.
33. Wong V., Xi-Li Fu A., George J., Wah Cheung N.: Thyotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis. Clin. Endocrin., 2002, 56, 793-798.
34. Prummel M.F., Laurberg P.: Interferon alpha and Autoimmune Thyroid Disease. Rev. Thyroid, 2003, 13, 547-551.
35. Parana R., Cruz M., Lyra L., Cruz T.: Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus. J. Virol. Hepatol., 2000, 7, 393-395.